Kiniksa Pharmaceuticals International, plc KNSA Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's tax on share settlement?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported tax on share settlement of $316K in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's tax on share settlement changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's tax on share settlement decreased by 23.3% year-over-year, from $412K to $316K.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's tax on share settlement?
- Over 3 years (2022 to 2025), Kiniksa Pharmaceuticals International, plc's tax on share settlement has grown at a 104.7% compound annual growth rate (CAGR), from $901K to $7.73M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.